Neurometabolic & Undiagnosed Neurological Diseases
State University of Liege, Belgium
Liege University Hospital, Belgium
Shaare Zedeck Medical Center, Jerusalem, Israel
Pediatric Neurology, Boston City Hospital and Tufts New England Medical Center, Boston, MANeurometabolic Diseases, Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MDMaster of Health Science in Clinical Research from Duke University, Durham, NC
American Neurological AssociationChild Neurology Society (USA)International Child Neurology AssociationAmerican Academy of NeurologyAmerican Society of Human GeneticsAmerican Society for Experimental TherapeuticsSociety for Inborn Metabolic Diseases (SIMD)
American Board of Psychiatry and Neurology with Special Qualification in Child Neurology
Raphael Schiffmann, M.D., M.H.Sc. specializes in solving diagnostic puzzles concerning neurological disorders of unknown cause. He currently serves as Medical Director of The Institute of Metabolic Disease at Baylor Research Institute. Dr. Schiffmann is Board Certified in Psychiatry and Neurology with Special Qualifications in Child Neurology. He joins an expert team of highly qualified laboratory directors who are available for expert consultation regarding assistance with ordering appropriate tests, interpretation of test results, and recommendations about additional testing. His interests include the mechanism and treatment of neurometabolic genetic diseases such as lysosomal storage disorders, enzyme replacement therapy, and leukodystrophies (genetic diseases affecting primarily the white matter of the brain).
Enzyme Replacement Therapies (ERT): Contact Dr. Schiffmann for information regarding ERT using Physician Investigational New Drug (IND) protocols. Free infusions for patients participating in clinical trials of novel ERT may be available.
Patient comments are gathered from our Press Ganey Satisfaction Survey and are displayed in their entirety.Patients are de-identified for confidentiality and patient privacy.